Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.42 |
| ▸ | PLK1 | P53350 | 2/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
| ▸ | ACR | P10323 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12731182 | 0.96 | L3MBTL1 (0.49) | L3MBTL1CYP3A4TDP1ALDH1A1TSHR | |
| SCHEMBL3715340 | 0.88 | TSHR (0.56) | L3MBTL1CYP3A4TDP1ALDH1A1TSHR | |
| SCHEMBL3721958 | 0.85 | CYP3A4 (0.53) | L3MBTL1CYP3A4TDP1ALDH1A1TSHR | |
| SCHEMBL5961855 | 0.84 | MAPT (0.50) | L3MBTL1CYP3A4TDP1TSHRMAPK1 | |
| SCHEMBL5961847 | 0.82 | KMT2A (0.54) | CYP3A4TSHRMAPK1KMT2AMAPT | |
| SCHEMBL5961764 | 0.81 | MAPT (0.45) | L3MBTL1CYP3A4TDP1ALDH1A1TSHR | |
| SCHEMBL13152962 | 0.80 | NPC1 (0.57) | CYP3A4ALDH1A1TSHRKMT2AMAPT | |
| SCHEMBL7147757 | 0.80 | MAPT (0.51) | L3MBTL1CYP3A4TDP1ALDH1A1TSHR | |
| SCHEMBL17229438 | 0.79 | POLB (0.51) | CYP3A4TDP1ALDH1A1TSHRMAPK1 | |
| SCHEMBL5961866 | 0.79 | NPC1 (0.47) | CYP3A4ALDH1A1TSHRKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168734-B2 | Lateral alpha-substituted acrylate compound and polymer thereof | JNC CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20110144293-A1 | LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF | CHISSO CORPORATION (JP) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144293-A1 | LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF | LEF1, AFF1, CNKSR1 | L3MBTL1 473/4885CYP3A4 4386/4885TDP1 2230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.